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Abstract 
Background: Minimal invasive cardiac surgery is cosmetically attractive to the 
patient; however, debate still exists regarding its safety and the effective exposure 
during the technique. We present our local experience in video assisted minimally 
invasive mitral valve replacement, for the surgically challenging rheumatic valve 
disease, still endemic among Egyptian population. 
Methods: This prospective single center study was conducted on 20 rheumatic 
heart patients, presenting with severe mitral regurgitation (8 patients; 40%), 
severe mitral stenosis (8 patients; 40%) or combined lesion (4 patients; 20%). The 
patients underwent video assisted minimally invasive mitral valve replacement, 
through a right mini-thoracotomy via: an infra-mammary incision (13 patients; 
65%), periareolar incision (4; 20%) or limited right anterolateral mini-thoracotomy 
(3 patients; 15%). Early postoperative quality of life was evaluated using SF 36 
questionnaire. 
Results: Mean length of skin incision was (6.60 ± 1.35 cm). Mean durations of 
operation, cardiopulmonary bypass, and cross-clamp times were: 4.32 ± 1.08, 2.85 
± 0.75 and 1.78 ± 0.47 hrs; respectively. The mean amount of blood loss was 398.50 
± 245.79 ml, with two patients (10%) requiring re-exploration. At discharge, all 
patients had normal prosthetic mitral valve function with no regurgitation by 
echocardiography. Four patients (20%) had atrial fibrillation postoperatively. Total 
durations of ICU stay and hospital stays were: 2.35 ± 1.14 and 6.45 ± 1.43 days, and 
90% of patients return to daily work and full activity within 4 weeks. 
Conclusions: Video assisted minimally invasive mitral valve surgery in rheumatic 
valve disease has low surgical trauma, blood loss, and pain, which translates into a 






Submitted: 2 Dec 2018 
Revised 1: 8 Dec 2018 
Revised 2: 17 Dec 2018
Accepted: 25 Dec 2018
Published: 5 Jan 2019
https://doi.org/10.35810/ects.v1i1.18
The Egyptian Cardiothoracic Surgeon 11 
Introduction 
    Over the last decade; different institutions 
have tried minimally invasive mitral valve surgery 
(MIMVS) and have published hopeful results as 
single-center studies [1]. Rheumatic fever 
increases valve thickness and contracture, 
making surgery more difficult in rheumatic than 
in degenerative valve disease [2]. Furthermore, 
due to the low prevalence of rheumatic fever in 
the western world, few reports have studied 
minimally invasive cardiac surgery in rheumatic 
patients [3]. This study presents our initial 
experience in MIMVS with video assistance for 
rheumatic mitral valve disease and evaluation of 
its early results and postoperative quality of life.  
Patients and Methods: 
This prospective single center descriptive 
study was conducted at Assiut University hospitals 
in the period between October 2015 and June 
2018. After ethical committee approval and 
informed written consent, 20 rheumatic patients 
presenting with either: mitral regurgitation (MR) 
(8 patients; 40%), mitral stenosis (MS) (8 patients; 
40%) or combined mitral valve lesion (4 patients; 
20%) were selected for this study. Patients were 
all candidates for first time isolated mitral valve 
replacement, of both sexes, with no limits of age. 
Preoperative data collected included; age, BMI, 
diabetes mellitus, and NYHA class. ECG was 
analyzed and echocardiography data were 
reported including left atrial (LA) dimension, left 
ventricular (LV) dimension, LV ejection fraction, 
mitral valve (MV) pathology, associated valve 
pathology and pulmonary hypertension. Patients 
older than 40 years benefited from a preoperative 
diagnostic coronary angiography to exclude 
associated coronary artery disease. Exclusion 
criteria were need of additional coronary artery 
bypass grafting or low ejection fraction <40%. 
Patients were also excluded for an expected 
technical burden in case of a previous right 
thoracotomy, femoral surgery or heavily calcific 
mitral valve annulus or deep annular abscess. 
After intravenous anesthesia including 
sufentanil and propofol, an arterial pressure line 
was placed in the right radial artery. Patients were 
then positioned in a supine position with the right 
side of the chest slightly elevated and right arm 
slightly abducted to clean out the axillary region 
for possible ports of the transthoracic aortic cross-
clamp (Chitwood clamp) (Scanlan International, St 
Paul, MN, USA) and telescope. The right shoulder 
was slightly elevated 30 degrees. Defibrillation 
pads were placed externally. Single lumen 
endotracheal tube was used in all cases. Tidal 
volume was reduced temporary by deflating the 
lung if necessary, until the lungs were 
disconnected after full cardiopulmonary bypass 
(CBP).  
Right 6-8 cm infra-mammary incision was 
carried out in 13 patients, right 5 cm periareolar 
incision of length in 4 patients and 5-8 cm right 
limited anterolateral thoracotomy incision of 
length in 3 patients. The chest was entered via the 
3rd or 4th intercostal space and a small pad is used 
to displace and retract the right lung. Synchronous 
exposure of femoral vessels through a 3cm supra 
inguinal oblique incision. The right femoral artery 
and vein were surgically exposed. After systemic 
heparinization, a femoral arterial cannula (12F to 
14F) was inserted to the femoral artery. Repair of 
this femoral arteriotomy was done, by 6/0 
polypropylene suturing at the end of the 
operation. A standard multistage femoral venous 
cannula (22- 24F) was placed in the femoral vein 
and advanced to the right atrium. 5/0 
polypropylene purse suture was used to secure 
the cannula and closure of the vein at the end of 
surgery in almost all cases.  
The pericardial sac was opened 3 cm above the 
right phrenic nerve and parallel to it. The 
 pericardium was fixed to the skin with three stay 
retraction sutures, with pulling the heart slightly 
to the right side and into the field to expose the 
roof of the left atrium. Aortic occlusion was 
achieved by either a transthoracic cross-clamp 
(Chitwood clamp; Scanlan International, St Paul, 
MN, USA) or via the same operative incision using 
a flexible or inflexible aortic clamp. A conventional 
cardiopulmonary bypass system was used under 
moderate hypothermia (28 to 30° C) then, the 
lungs were deflated. The Cardioplegic solution was 
delivered into ascending aorta. 
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Figure 1: Mitral valve replacement performed: A) combination of direct vision & thoracoscopic assistance, with the 
use of (Obadia) set of minimally invasive instruments; B) Video-assisted minimally invasive mitral valve replacement 
through right mini-thoracotomy 
After complete cardiac arrest, the left atrium 
was opened and the mitral valve was exposed. 
Mitral valve replacement was performed with 
partial or total chordal preservation and under a 
combination of direct vision and thoracoscopic 
assistance through three-dimensional videoscopic 
guidance, with the use of special set of minimally 
invasive instruments, (OBADIA set) (created by 
Obadia J F, Hôpital Louis Pradel - Lyon - France) 
(Figure 1A). We performed some surgical steps 
with video assistance, such as placement of 
sutures on the anterior annulus of the mitral valve, 
or the area of the posteromedial commissure.  
After completion of the procedure, the left 
atrium was closed by a continuous suturing. 
Dearing was achieved by filling the left atrium with 
saline before its closure or by suction via the 
cardioplegic cannula into the ascending aorta. It 
was associated with the inflation of the lungs. 
After appropriate reperfusion, the arterial and 
venous cannulas were removed and the femoral 
vessels reconstructed. The chest wound was 
closed after putting a drainage tube.
  
All patients were assessed regarding bleeding, 
postoperative pain, respiratory complications, 
wound healing, pericardial effusion, total hospital, 
and ICU stay in days. Complications related to 
femoral cannulation like ischemia, emboli or 
bleeding were recorded. 
All patients were assessed postoperatively and 
before discharge using echocardiography 
regarding prosthetic mitral valve function and 
pressure gradient, paravalvular leak, LV function, 
and pericardial effusion. SF-36 questionnaire for 
the quality of life was applied to each patient from 
one month to three months postoperatively. The 
SF-36 Health Survey is a multi-purpose, short-form 
health survey which contains 36 questions. It 
yields an eight-scale profile of scores as well as 
summary physical and mental measures [4]. 
Statistical analysis: 
 Data were expressed as numbers (%) for 
categorical variables or mean + SD and range for 
continuous variables. 
Results: 
The study population included 20 patients 
who underwent video-assisted minimally invasive 
mitral valve surgery at Cardiothoracic Surgery 
Department - Assiut University Hospital.  
Patients’ demographic data are presented in 
Table 1. 
Operative data 
All mitral valve operations were Video-
assisted through right mini-thoracotomy (Figure 
1B). 13 patients (65%) were via infra-mammary 
incisions (Figure 2A), 4 patients (20%) were via 
periareolar incision (Figure 2B) and three patients 
(15%) were via limited anterolateral mini-
thoracotomy, the length of incision was between 
5 to 10 cm with (Mean ± SD= 6.60 ± 1.35 cm) with 




patients having incisions of 6 cm or less. No 
reported patients needed conversion to an 
enlarged thoracotomy incision, a mini-sternotomy 
or complete sternotomy. 
Table 1: Demographic data of the studied population 
No. (n= 20) % 
Age (years) 
Mean ± SD 35.50 ± 13.83 
Range 16.0 - 66.0 
Sex 
Male 5 25.0 
Female 15 75.0 
Body surface area (Kg/m2) 
Mean ± SD 1.64 ± 0.26 
Range 1.2 - 2.2 
Diabetes mellitus 
Diabetic 3 15.0 
Non-diabetic 17 85.0 
NYHA class 
Class III 15 75.0 
Class IV 5 25.0 
ECG 
AF 6 30.0 
Sinus 14 70.0 
Echo 
Severe MR 8 40.0 
Severe MS 8 40.0 




Mean ± SD 61.15 ± 6.58 
Range 43.0 - 70.0 
Mean duration of operation, cardiopulmonary 
bypass, and cross-clamp times were (4.32 ± 1.08, 
2.85 ± 0.75 and 1.78 ± 0.47 hr.) respectively, with 
range (2.5 - 6.0, 2.0 - 5.0 and 1.0 - 2.5 hr.) 
respectively.  
Nineteen patients (95%) underwent femoro-
femoral cannulation and one patient (5%) 
underwent aorto-bicaval cannulation. Fifteen 
patients (75%) underwent mitral valve 
replacement (MVR) by St-Jude medical 
mechanical valve size 27 and 5 patients (5%) by 
size 25 (St. Jude Medical, Inc., Minnesota, USA); 
according to intraoperative sizing of the mitral 
annulus (Table 2). 
Post-operative data 
Primary ventilation time was between 1.0 - 
4.0 hours, (mean ± SD = 2.00 ± 0.79 hrs.). ICU stay 
ranged between 1.0 - 3.0 day with (mean ± SD = 
2.35 ± 1.14), and hospital stay ranged between 5.0 
- 7.0 days with (mean ± SD = 6.45 ± 1.43). 
The amount of blood loss ranged between 
170.0 - 1000.0 ml (mean ±SD = 398.50 ± 245.79) 
with two patients requiring re-exploration for 
bleeding through the same primary operative 
incision. About 13 patients (65%) didn't need 
blood transfusion, 4 patients (20%) needed 1– 2 
units and 3 patients (15%) needed more than 2 
units. 
All patients had no incidence of neurological 
events. 16 patients (80%) were in sinus rhythm 
and 4 patients (20%) had AF postoperatively 
without the need for external defibrillations. At 
discharge, all patients had normal prosthetic 
mitral valve function with no regurgitation, no 
paravalvular leakage. 
Mean pressure gradient (PG) ranged between 
4 -5 mmHg (mean ± SD = 4.40 ± 0.50), as shown on 
postoperative echocardiography. No patient had 
pleural effusion or wound infection. 
In 18 patients, wound healing at the groin was 
uncomplicated. Two patients had a lymphatic 
collection in the groin, which was treated 
conservatively (Table 3). 
SF-36 Questionnaire for Quality of Life: 
In our study, quality of life was measured for 
all patients from 1 to 3 months postoperatively by 
SF-36 Questionnaire. The SF-36 Questionnaire 
Health Survey contains 36 questions and gives 
eight-scale profile as well as summary physical 
and mental measures (Table 4; Figure 3). 
Discussion 
The Society of thoracic surgeons (STS) defined 
minimally invasive (MI) surgery as any technique 
not including full sternotomy [5]. In recent years, 
MI surgery is preferable to the patients because of 
the minimal trauma, small incision and quick 
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Figure 2: Right mini-thoracotomy via: A) infra-mammary 6-cm incision, B) Periareolar incision 
Table 2: Operative data 
No. (n= 20) % 
Type of incision 
Right mini-thoracotomy 









length of Incision (cm) 
Mean ± SD 6.60 ± 1.35 
Range 5.0 - 10.0 
Operative time (hours) 
Mean ± SD 4.32 ± 1.08 
Range 2.5 - 6.0 
Bypass time (hours) 
Mean ± SD 2.85 ± 0.75 
Range 2.0 - 5.0 
Cross-clamp time (hours) 
Mean ± SD 1.78 ± 0.47 
Range 1.0 - 2.5 
Cannulation 
     Femoro-femoral   19 95.0 
Aorto-femoral bicaval 1 5.0 
Procedure 
MVR by St-Jude medical 
27
15 75.0 




recovery [6]. We have adopted minimally invasive 
cardiac surgery at our hospital since 2011 and 
used it to treat ASD cases without video 
assistance. Then, after getting a good initial 
experience with the technique, we applied the 
technique on more demanding pathology. 
In spite of the improvement in healthcare and 
living standards in recent years, rheumatic fever is 
still endemic among Egyptian population. 
Rheumatic valvular lesions are thick and cause 
calcification and adhesion of valve leaflets, so their 
surgical manipulation is difficult, in comparison 
with other pathologies [7]. All our patients had 
rheumatic mitral valve disease, while previous 
studies focused mainly on patients having a 
degenerative disease or mixed pathology. Seventy 
percent of the patients of Mattia and associates 
who benefited from MIMVS through the right 
anterolateral thoracotomy presented with 
degenerative mitral valve pathology, compared 
to only 9.4% being of rheumatic origin. [8]. Few 
recent minimally invasive studies were reported 
on rheumatic valves; Junyu Zhai, and associates 
[7], a Chinese study that used thoracoscope for 
removal the damaged native mitral valve only; 
Vivek Kanhere and colleagues [9], an Indian study 
without video assistance and Noedir Antonio and 
associates [10], a Brazilian study used 
thoracoscope mainly for commissurotomy of 
stenotic mitral valve. The procedure was 
technically feasible in all our cases, with mean 
operative, ischemic and bypass times that were 
comparable to those reported by other studies 
[11].   
A B 
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Table 3: Post-operative data 
No. (n= 20) % 
Amount of blood transfusion (unit) 
None 13 65.0 
1 - 2 4 20.0 
> 2 3 15.0 
Ventilation time (hours) 
Mean ± SD 2.00 ± 0.79 
Range 1.0 - 4.0 
ICU stay (days) 
Mean ± SD 2.35 ± 1.14 
Range 1.0 - 3.0 
Hospital stay (days) 
Mean ± SD 6.45 ± 1.43 
Range 5.0 - 7.0 
Amount of bleeding (cc) 
Mean ± SD 398.50 ± 245.79 
Range 170.0 - 1000.0 
ECG 
AF 4 20.0 
No 16 80.0 
Prosthetic valve PG mean (mmHg) 
Mean ± SD 4.40 ± 0.50 
Range 4.0 - 5.0 
In the study of Mohr FW and colleagues, 
patients underwent video-assisted minimally 
invasive mitral valve replacement through a right 
lateral mini-thoracotomy, the mean length of 
incision was (5.4 ± 1.8 cm) (range 3.8 to 8 cm) 
[11]. Although the mean length of our incisions 
was larger, yet all incisions were 6 cm or smaller 
in the last 17 patients (85%), providing a 
favorable cosmetic for the patients. None of our 
patients needed conversion to an enlarged 
thoracotomy incision, a mini-sternotomy or 
complete sternotomy. 
Minimally invasive approaches appear to be 
associated with faster recovery, earlier discharge, 
and reduced use of rehabilitation facilities [12]. 
Mihaljevic and colleagues [13] reported a shorter 
hospital stay with a minimally-invasive approach. 
Also, Mohr FW and colleagues [11] revealed that 
mean duration of intensive care and hospital stays 
were 2 days (range 1 to 36 days) and 13 days (10 
to 36 days) respectively. Our patients benefited 
from a comparable ICU stay and even shorter total 
hospital stay that varied between 5 and 7 days.  
Small incisions significantly reduce morbidity 
and mortality associated with transfusions and 
bleeding re-exploration [14]. 
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Some studies showed no difference in blood 
transfusion requirements [15], whereas Dogan 
and associates [16] reported a significant 
reduction in postoperative bleeding in the 
minimally invasive group in comparison with the 
traditional group. Two-thirds of our patients did 
not need any blood transfusion and only 2 cases 
required re-exploration for non-surgical bleeding, 
without requiring to enlarge the incision.  
Due to the physical limitations of minimally 
invasive surgery, inadequate de-airing leading 
theoretically to a higher incidence of neurological 
complications [6]. We did not encounter any 
neurological complications among our small group 
of patients.  In the early series, Seeburger and 
associates [17] observed postoperative 
neurological complications in 41 of 1,339 patients 
(3.1%) who underwent MIMVS, with 28 minor and 
13 major events. Also, in Mattia Glauber and 
colleagues [8] a total of 1604 consecutive 
patients underwent MIMVS through a right 
anterolateral thoracotomy, he found excellent 
outcomes. On the other hand, prolonged cross-
clamp and cardiopulmonary bypass times were 
associated with a higher incidence of neurological 
events, aortic dissection; Gaudiani VA and 
associates [18] reported no difference in the 
incidence of stroke. 
Theoretically, it has been suggested that a less 
traumatic surgical approach would trigger less 
post-operative AF. However, a meta-analysis of 4 
eligible studies revealed no significant difference 
between minimally invasive and sternotomy 
approaches about AF [6]. In their study on 1000 
patients who underwent minimally invasive mitral 
valve surgery, Scott McClure and associates 
detected postoperative AF in as much as 20% of 
patients [19]. In our study, the percentage of AF 
decreased after surgery. Out of 6 patients 
presented with AF before surgery, AF persisted in  
only four cases postoperatively, with the 
remaining 16 patients (80%) being in sinus rhythm. 
On the other hand, there is a general agreement 
that minimal invasive surgery permits excellent 
visualization for leaflet resection and to perform 
uncomplicated mitral valve replacement [11].  
Postoperative echocardiographic studies 
showed normal prosthetic valve function in all 
cases, with minimal or no regurgitation. 
The right thoracotomy approach may be 
associated with more respiratory complications 
[8,11]. Mattia and colleagues pulmonary 
complications in as much as 41 patients (2.5%) 
[8]. Mohr and colleagues reported 2 mortalities 
from severe pneumonia at the 6th postoperative 
day in one case and from pulmonary embolism 
on the 24th postoperative day, despite adequate 
anticoagulation [11]. None of our 20 cases has 
encountered any respiratory complication. 
Table 4: SF-36 Questionnaire for Quality of Life 
Mean ± SD Range 
Physical functioning 95.40 ± 6.03 83.0 - 100.0 
Role of limitation due to physical health 100.00 ± 0.00 100.0 - 100.0 
Role of limitation due to emotional health 100.00 ± 0.00 100.0 - 100.0 
Energy/ fatigue 94.00 ± 3.48 90.0 - 100.0 
Emotional well being 93.95 ± 5.72 80.0 - 100.0 
Social functioning 97.60 ± 4.92 88.0 - 100.0 
Pain 89.80 ± 9.08 78.0 - 100.0 
General health 91.80 ± 9.98 56.0 - 100.0 
Health change 100.00 ± 0.00 100.0 - 100.0 
SF-36 95.84 ± 2.31 91.2 - 99.6 
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The incidence of septic complications and 
wound infections is lower with a thoracotomy 
than with a median sternotomy [20]. Grossi and 
colleagues [20] reported an incidence of 0.9% for 
mini-thoracotomy and 5.7% for sternotomy cases. 
This had increased to 1.8% and 7.7%  respectively 
in elderly patients, whereas Felger and
associates [21] reported no significant 
differences between groups. It is important to 
note that there is an additional risk of groin 
complications associated with minimally invasive 
surgery. Mohr and colleagues [11] reported three 
patients with groin healing complication, two 
patients had a small residual hematoma and one 
patient had a lymph fistula in the right groin; all of 
which were treated conservatively. In our study, 
only one patient developed groin lymphatic 
collection but all our thoracotomies were clean.  
Jeronimo A F Junior and associates [22] 
observed better cosmetic results, reduced 
postoperative pain and rapid recovery after the 
thoracotomy approach. Casselman and associates 
[23] reported that approximately 99% of patients 
thought that their right thoracotomy scar was 
esthetically pleasing. In our study, improved 
cosmoses are one of the benefits of minimally 
invasive surgery and 95% of our patients were 
appreciated the cosmetic appearance of their 
scar. 
Postoperative pain and quality of life were 
evaluated by Leipzig group of Walther and 
associates from 1996 to 1997 using different 
scoring systems [24]. Another study assessed 
Quality of life by using modification of the 
Nottingham Health Questionnaire (NHQ) [25]; 
with analysis of different aspects of QOL (Quality 
of life), mainly social status, mobilization, 
emotional state, level of activities, pain, and 
sleeping disorders. That group found less pain 
starting from the third postoperative day after a 
lateral mini-thoracotomy. It is suggested that 
better stability of the bony thorax leads to earlier 
mobilization and return to daily activities [24]. 
Casselman and associates [23] reported that no 
or mild postoperative pain in 94% of their 
patients and 46% returned to work within 3 
weeks. Yamada and colleagues compared the 
early postoperative 
quality of life in minimally invasive valve surgery 
and conventional surgery. They found earlier 
recovery of daily activities after minimally invasive 
surgery. It provides an improved quality of life 
and reduced use of pain medication [15]. In our 
study, 90% of patients return to daily work and 
full activity within 4 weeks. 
Limitations of the study: 
Although the study reported the feasibility of 
the technique in rheumatic patients, yet the 
number of cases and absence of a comparative 
group are limitations of this study. 
Conclusion: 
Our preliminary study revealed that video 
assisted minimally invasive mitral valve 
replacement is safe and applicable in rheumatic 
patients. The results in this series are comparable 
to the world literature. It is effective in reducing 
hospital stay, blood transfusion, and 
postoperative pain. It provides a good cosmetic 
appearance and fast recovery of usual activities. 
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